Status:
COMPLETED
Living With Statins - The Impact of Cholesterol Lowering Drugs on Health, Lifestyle and Well-being
Lead Sponsor:
University of Copenhagen
Conditions:
Cardiovascular Disease
Diabetes Mellitus
Eligibility:
All Genders
40-70 years
Phase:
PHASE4
Brief Summary
Background Statins are cholesterol lowering drugs that are prescribed to lower the risk of cardio-vascular diseases. The use of statins has increased markedly and it is now one of the most prescribed ...
Detailed Description
Background HYPERCHOLESTEROLEMIA AND STATIN USE IN DENMARK Simvastatin is the most commonly prescribed statin, a class of drugs that inhibit hydroxyl-methyl-glutaryl (HMG) coenzyme A reductase, and t...
Eligibility Criteria
Inclusion
- 40-70 years.
- BMI 25-35.
- prescribed Simvastatin 40 mg/daily by their general practitioner.
Exclusion
- Diabetes Mellitus.
- Cardiovascular disease such as arrythmia, ischaemic heart disease.
- Musculoskeletal disorders preventing the subject to perform physical.
- Mental disorders preventing the subject to understand the project description.
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT02255682
Start Date
January 1 2015
End Date
December 1 2016
Last Update
January 4 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Copenhagen
Copenhagen, Denmark, 2200